Oaktree Acquisition Corp. III Life Sciences Class A (OACC) Stock Statistics & Valuation Metrics

Oaktree Acquisition Corp. III Life Sciences Class A has a market cap or net worth of $263.40M. The enterprise value is $260.54T.

Market Cap

$263.40M

Enterprise Value

$260.54T

Oaktree Acquisition Corp. III Life Sciences Class A has 19,783,010 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

19,783,010

Owned by Insiders

27.21%

Owned by Institutions

18.22%

Oaktree Acquisition Corp. III Life Sciences Class A’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is -0.59%.

Return on Equity (ROE)

0.04

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

-0.59%

Return on Capital Employed (ROCE)

-0.01

Revenue Per Employee

0

Profits Per Employee

2.43M

Employee Count

3

Asset Turnover

0.00

Inventory Turnover

0.00

The current PE Ratio of Oaktree Acquisition Corp. III Life Sciences Class A is 58.42. Oaktree Acquisition Corp. III Life Sciences Class A’s PEG ratio is -1.64.

PE Ratio

58.42

PS Ratio

0.00

PB Ratio

1.04

Price to FCF

-435.22

Price to Operating Cash Flow

-339.91

PEG Ratio

-1.64

In the last 12 months, Oaktree Acquisition Corp. III Life Sciences Class A had revenue of 0 and earned 7.29M in profits. Earnings per share was 0.30.

Revenue

0

Gross Profit

0

Operating Income

-1.20M

Pretax Income

7.29M

Net Income

7.29M

EBITDA

-1.20M

Earnings Per Share (EPS)

0.30

In the last 12 months, operating cash flow was -603.24K and capital expenditures 0, giving a free cash flow of -603.24K billion.

Operating Cash Flow

-603.24K

Free Cash Flow

-603.24K

Free Cash Flow per Share

-0.03

Oaktree Acquisition Corp. III Life Sciences Class A pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-0.23%

Earnings Yield

2.11%

Beta

0.05

52-Week Price Change

1.56%

50-Day Moving Average

10.74

200-Day Moving Average

10.69

Relative Strength Index (RSI)

50.06

Average Volume (3m)

47.78K

Oaktree Acquisition Corp. III Life Sciences Class A as a current ratio of 1.19, with Debt / Equity ratio of 0.01%

Current Ratio

1.19

Quick Ratio

1.19

Debt to Market Cap

0.00

Net Debt to EBITDA

1.19

Interest Coverage Ratio

0.00

In the past 12 months, Oaktree Acquisition Corp. III Life Sciences Class A has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Oaktree Acquisition Corp. III Life Sciences Class A EV to EBITDA ratio is -77.89, with an EV/FCF ratio of -433.21.

EV to Sales

0.00

EV to EBITDA

-77.89

EV to Free Cash Flow

-433.21

EV to Operating Cash Flow

-433.21

Oaktree Acquisition Corp. III Life Sciences Class A has $1.23M in cash and marketable securities with $0.00 in debt, giving a net cash position of $1.23M billion.

Cash & Marketable Securities

$1.23M

Total Debt

$0.00

Net Cash

$1.23M

Net Cash Per Share

$0.06

Tangible Book Value Per Share

$10.28

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin

0.00%

Operating Margin

0.00%

Pretax Margin

0.00%

Net Profit Margin

0.00%

EBITDA Margin

0.00%

EBIT Margin

0.00%

The average price target for Oaktree Acquisition Corp. III Life Sciences Class A is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

―

EPS Growth Forecast

39.00%

Smart Score

4

AI Score

―